Monkeypox Case Landed in England
The UK Health Security Agency (UKHSA) confirmed yesterday an individual had been diagnosed with monkeypox in England. The patient recently visited Nigeria before traveling to the UK.
As a precautionary measure, the UKHSA stated on May 7, 2022, people in close contact with this individual would be contacted to provide health advice.
This is because a monkeypox infection can spread when someone is in close contact with an infected person.
If the air passengers are not reached, there is no action they should take, says the UKHSA.
However, there is a very low risk of transmission to the general population.
In a related media release, Dr. Colin Brown, Director of Clinical and Emerging Infections, UKHSA, stated, "It is important to emphasize that monkeypox does not spread easily between people, and the overall risk to the general public is very low."
Monkeypox is a rare viral infection, usually a mild self-limiting illness, with most people recovering within a few weeks.
However, severe illness can occur in some individuals.
The first human case of monkeypox was recorded in 1970 in Africa during a period of intensified effort to eliminate smallpox, says the U.S. CDC.
Since then, monkeypox has been reported in humans in other central and western African countries, including Nigeria.
In the USA, monkeypox cases are sporadic, however, there have been two travel-associated cases in 2021 reported by the CDC.
Persons exposed to the monkeypox virus and who have not received the smallpox vaccine within the last three years should consider getting vaccinated.
To protect people, Bavarian Nordic's Jynneos vaccine (Imvamune or Imvanex) was approved by the U.S. FDA.
The CDC's Advisory Committee on Immunization Practices is currently evaluating Jynneos for those at risk of occupational exposure to orthopoxviruses such as smallpox and monkeypox in a pre-event setting.
Note: This information was edited and manually curated for mobile readers.